Delivery Order SPE2DB22D1200-SPE2DB25FN4GA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,644.62 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on July 25, 2025, with a completion date of July 28, 2025. This is a firm fixed-price, non-competitive delivery order with no set-aside designation, issued to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a standard pharmaceutical procurement supporting the federal government's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,700.12 on July 28, 2025, for the supply of Mounjaro 12.5 mg/0.5 ml pen injections. This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 29, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,722.19 to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 mL pen injections on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,082.99 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pen injectors on July 24, 2025. This firm fixed-price delivery order, which is a child contract under a larger indefinite delivery vehicle, represents a routine pharmaceutical procurement for military healthcare needs. The contract was competitively awarded without set-aside designation and specifies performance at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,408.25 on July 28, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This non-competitive delivery order, with a completion date of July 29, 2025, will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract utilizes firm fixed pricing and represents a child order under a larger contract vehicle supporting federal medical procurement needs. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,492.12 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens. The contract, which was competitively awarded with no set-aside designation, carries a firm fixed price structure and is scheduled for completion by July 23, 2025. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 ml pen injectors, with a ceiling value of $1,088.36. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 18, 2025. The delivery order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,888.99 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and represents a continuation of the company's critical role as a pharmaceutical supplier to federal military and healthcare systems. The place of performance...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors valued at $7,605.13. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,265.71 by the Defense Logistics Agency (DLA) for the supply of Mounjaro 5 mg/0.5 ml pen injectors. This firm fixed-price delivery order, awarded on July 31, 2025, with completion targeted for August 1, 2025, represents a small-value pharmaceutical transaction under the company's broader contracting relationship with DLA. The contract involves no set-aside designation, indicating it was competitively awarded through open...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB25FN4GADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,102.53 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. The contract employs firm fixed pricing and was competitively awarded with no set-aside designation. Performance will be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026, which serves as the primary pharmaceutical supply vehicle for military and federal healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies to Department of Defense health systems, including the Defense Health Agency and U.S. Coast Guard. The company's comprehensive contract portfolio demonstrates capabilities across multiple therapeutic domains, including specialty medications, brand-name and generic pharmaceuticals, and medical devices. As a prime vendor under the DLA Troop Support Medical contract, AmerisourceBergen supplies a wide range of pharmaceutical products essential to military healthcare operations globally, positioning it as a key strategic partner in federal medical procurement for the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.1k | 9/8/25 |